BioNexus Gene Lab (BGLC) EBITDA (2018 - 2026)
BioNexus Gene Lab recorded quarterly EBITDA of -$521675.0 in Q1 2026, up 50.05% quarter-over-quarter from -$1.0 million in Q4 2025, and up 5.35% year-over-year from -$495178.0 in Q1 2025.
BioNexus Gene Lab's EBITDA history runs 9 years deep, the most recent figure standing at -$521675.0 for Q1 2026.
- In Q1 2026, EBITDA rose 5.35% year-over-year to -$521675.0; the TTM figure through Mar 2026 stood at -$2.5 million (down 47.11% YoY), while the FY2025 annual figure was -$2.6 million, down 72.78% from the prior year.
- EBITDA came in at -$521675.0 for Q1 2026 at BioNexus Gene Lab, up from -$1.0 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $431764.0 in Q4 2023 to a low of -$2.6 million in Q3 2023.
- A 5-year average of -$477065.9 and a median of -$397993.0 in 2022 frame the typical range for EBITDA.
- Across the five-year window, EBITDA sank 2294.97% in 2022 and soared 133.98% in 2024, its largest moves.
- BioNexus Gene Lab's EBITDA stood at $241359.0 in 2022, then jumped by 78.89% to $431764.0 in 2023, then tumbled by 346.75% to -$1.1 million in 2024, then increased by 1.98% to -$1.0 million in 2025, then soared by 50.05% to -$521675.0 in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$521675.0, -$1.0 million, and -$705775.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 2.44 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | 837.00 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 810.90 Mn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 712.00 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 752.70 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 657.00 Mn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 239.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 300.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -521,675.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -521,675.00 |
| Dec 31, 2025 | -1.04 Mn |
| Sep 30, 2025 | -705,775.00 |
| Jun 30, 2025 | -249,094.00 |
| Mar 31, 2025 | -551,168.00 |
| Dec 31, 2024 | -1.07 Mn |
| Sep 30, 2024 | -298,581.00 |
| Jun 30, 2024 | 201,567.00 |
| Mar 31, 2024 | -313,665.00 |
| Dec 31, 2023 | 431,764.00 |
| Sep 30, 2023 | -2.63 Mn |
| Jun 30, 2023 | -593,142.00 |
| Mar 31, 2023 | -108,105.00 |
| Dec 31, 2022 | 241,359.00 |
| Sep 30, 2022 | -397,993.00 |
| Jun 30, 2022 | -456,422.00 |
| Mar 31, 2022 | -51,710.00 |
| Dec 31, 2021 | 128,173.00 |
| Sep 30, 2021 | 238,382.00 |
| Jun 30, 2021 | 20,794.00 |
| Mar 31, 2021 | 130,276.00 |
| Dec 31, 2020 | -20,308.00 |
| Sep 30, 2020 | 482,528.00 |
| Jun 30, 2020 | 7,717.00 |
| Mar 31, 2020 | 774,948.00 |
| Dec 31, 2019 | -71,447.00 |
| Sep 30, 2019 | -32,830.00 |
| Jun 30, 2019 | -87,998.00 |
| Mar 31, 2019 | -44,322.00 |
| Dec 31, 2018 | -97,754.00 |
| Sep 30, 2018 | -82,529.00 |
| Mar 31, 2018 | 273,614.00 |